Replies to post #2533 on Ariad Pharmaceuticals Inc fka ARIA

[BTH]

Any news regarding rida will come form MRK not Ariad. Perhaps you should direct your complaint about the lack of PR to the MRK board.

And if you read the rest of my message, you would see that my gripe is not with Merck, but the slowness of how Ridaforolimus has evolved as opposed to the other companies with mTORS currently on the market (and approved for over a year now). All 3 companies (Wyeth, Ariad, Novartis), started trialing their mTORs roughly the same time - yet, Ariad is about 2-3 years late to the game.